NFKB1 and infection: The immunosuppression and subsequent increased infection risk associated with glucocorticoid use are thought to result from impaired phagocytosis and suppression of humoral immunity (decreased function of B-lymphocytes) and cell-mediated immunity through inhibition of pro-inflammatory genes such as NF-kB and AP-1 through trans-repression [12,21,29-37].